Neurology - Medicine.net

Researchers show multiple sclerosis drug can be used as Alzheimer's therapy

by Lindsay Travis,University of KentuckyWorking model for the effect of ponesimod on microglial activation and phagocytosis. Aβ42 binds to TLR4 and induces a complex with S1PR1. S1P co-activates

Updated on: March 02,2024

Researchers show multiple sclerosis drug can be used as Alzheimer's therapy

by Lindsay Travis,University of KentuckyWorking model for the effect of ponesimod on microglial activation and phagocytosis. Aβ42 binds to TLR4 and induces a complex with S1PR1. S1P co-activates

Updated on:March 02,2024

Landmark study finds dementia risk varies significantly among racial and ethnic groups

by Kaiser PermanenteDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.In the largest and longest study thus far of ethnic disparities in dementia risk

Updated on: February 27,2024

Landmark study finds dementia risk varies significantly among racial and ethnic groups

by Kaiser PermanenteDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.In the largest and longest study thus far of ethnic disparities in dementia risk

Updated on:February 27,2024

Symptom persistence during first year following traumatic brain injury

by Mary Ann Liebert, IncNumber of symptoms endorsed at any severity by traumatic brain injury (TBI) severity subgroup and time. mTBI, mild TBI (admission Glasgow Coma Scale score 13–15); msTBI, m

Updated on: February 03,2024

Symptom persistence during first year following traumatic brain injury

by Mary Ann Liebert, IncNumber of symptoms endorsed at any severity by traumatic brain injury (TBI) severity subgroup and time. mTBI, mild TBI (admission Glasgow Coma Scale score 13–15); msTBI, m

Updated on:February 03,2024

Protein shapes matter in Alzheimer's research

by Allison Mills,Michigan Technological UniversityCellular toxicity, which is higher in amyloid amorphous aggregates, shows that small changes in protein folding chemistry can cause differences

Updated on: April 16,2024

Protein shapes matter in Alzheimer's research

by Allison Mills,Michigan Technological UniversityCellular toxicity, which is higher in amyloid amorphous aggregates, shows that small changes in protein folding chemistry can cause differences

Updated on:April 16,2024

Women's blood lipid metabolism found to be better at countering effects of sleep apnea

by University of OttawaSubjects were seated for six hours with an intravenous catheter to measure blood lipids, breathing medical nitrogen to simulate sleep apnea. Credit: University of OttawaSle

Updated on: March 05,2024

Women's blood lipid metabolism found to be better at countering effects of sleep apnea

by University of OttawaSubjects were seated for six hours with an intravenous catheter to measure blood lipids, breathing medical nitrogen to simulate sleep apnea. Credit: University of OttawaSle

Updated on:March 05,2024

Is that 'midlife crisis' really Alzheimer's disease?

by Carmela Tartaglia,The ConversationCredit: AI-generated imageImagine you tell your 55 year-old mom you're going to get married and she's too disorganized to help you with the wedding p

Updated on: March 13,2024

Is that 'midlife crisis' really Alzheimer's disease?

by Carmela Tartaglia,The ConversationCredit: AI-generated imageImagine you tell your 55 year-old mom you're going to get married and she's too disorganized to help you with the wedding p

Updated on:March 13,2024

How antidepressants, ketamine and psychedelic drugs may make brains more flexible—new research

by Barbara Jacquelyn Sahakian and Christelle Langley,The ConversationCredit: Juan Gaertner/ShutterstockThe first-line pharmacological treatment for major depressive disorder (MDD) are antidepres

Updated on: January 12,2024

How antidepressants, ketamine and psychedelic drugs may make brains more flexible—new research

by Barbara Jacquelyn Sahakian and Christelle Langley,The ConversationCredit: Juan Gaertner/ShutterstockThe first-line pharmacological treatment for major depressive disorder (MDD) are antidepres

Updated on:January 12,2024

Blood oxygen levels could explain why memory loss is an early symptom of Alzheimer's

by University of SussexCredit: Fakurian DesignIn a world first, scientists from the University of Sussex have recorded blood oxygen levels in the hippocampus and provided experimental proof for w

Updated on: March 09,2024

Blood oxygen levels could explain why memory loss is an early symptom of Alzheimer's

by University of SussexCredit: Fakurian DesignIn a world first, scientists from the University of Sussex have recorded blood oxygen levels in the hippocampus and provided experimental proof for w

Updated on:March 09,2024

Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that

Updated on: April 16,2024

Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that

Updated on:April 16,2024

COVID-19: Advice for caring for people with Alzheimer's disease, mild cognitive impairment

by From Mayo Clinic News NetworkCredit: CC0 Public DomainWith the COVID-19 pandemic at the forefront of daily life, how much information should you share with a loved one who has Alzheimer's disea

Updated on: March 26,2024

COVID-19: Advice for caring for people with Alzheimer's disease, mild cognitive impairment

by From Mayo Clinic News NetworkCredit: CC0 Public DomainWith the COVID-19 pandemic at the forefront of daily life, how much information should you share with a loved one who has Alzheimer's disea

Updated on:March 26,2024

'Anti-tangle' molecule could aid search for new dementia treatments, say scientists

by Vicky Just,University of BathThe solution NMR structure of αS1–25(A) The average structure of αS1–25derived from the 20 lowest-energy structures. Charged (blue: positive, red: negative)